Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Circulation

• Publication date

  1991-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.84.6.2426PMID 1683602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.

  1991cited by this paper
• Usefulness of bucindolol in congestive heart failure.

  1990cited by this paper
• Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.

  1990cited by this paper
• Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.

  1990cited by this paper
• Mechanism of Action of Bucindolol in Human Ventricular Myocardium

  1990cited by this paper
• Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.

  1989cited by this paper
• Neurohormonal interactions and adaptations in congestive heart failure.

  1988cited by this paper
• Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

  1986cited by this paper
• Coronary artery cardiomyopathy. Hemodynamic and prognostic implications.

  1986cited by this paper
• Hemodynamic properties of bucindolol, a beta-adrenoreceptor blocking drug with vasodilator activity.

  1986cited by this paper
• Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.

  1985cited by this paper
• Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise.

  1985cited by this paper
• Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension.

  1984cited by this paper
• Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.

  1984cited by this paper
• Functional left ventricular aneurysm formation after acute anterior transmural myocardial infarction. Incidence, natural history, and prognostic implications.

  1984cited by this paper
• A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group.

  1983cited by this paper
• Cardiomyopathy: how far have we come in 25 years, how far yet to go?

  1983cited by this paper
• Beta-blockers in dilated cardiomyopathies: they work.

  1983cited by this paper
• Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.

  1981cited by this paper
• Presynaptic regulation of the release of catecholamines.

  1980cited by this paper
• Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations.

  1979cited by this paper
• Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine.

  1977cited by this paper
• Treadmill exercise in assessment of the functional capacity of patients with cardiac disease.

  1972cited by this paper

• Clinical and Basic Cardiology

  2023cites this paper
• Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis

  2023cites this paper
• Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

  2021cites this paper
• Efficacy of Add-on Therapy with Carvedilol and the Direct Renin Inhibitor Aliskiren for Improving Cardiac Sympathetic Nerve Activity, Cardiac Function, Symptoms, Exercise Capacity and Brain Natriuretic Peptide in Patients with Dilated Cardiomyopathy.

  2021cites this paper
• OBSOLETE: Neurohormonal Blockade

  2018cites this paper
• Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

  2017cites this paper
• Pharmacokinetic drug evaluation of bucindolol for the treatment of atrial fibrillation in heart failure patients

  2017cites this paper
• Heart Failure and Sudden Cardiac Death.

  2017cites this paper
• Effect of Beta-blocker Treatment on V˙O2peak in Patients with Heart Failure

  2017cites this paper
• A genotype‐directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC‐AF trial

  2017cites this paper
• A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure

  2016cites this paper
• Clinical Characteristics and Treatment of Cardiomyopathies in Children

  2016cites this paper
• A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure

  2016cites this paper
• Cardiovascular Effects of Cancer Therapy

  2015cites this paper
• Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure

  2015cites this paper
• Autonomic Neuroscience: Basic and Clinical

  2013cites this paper
• Effects of β‐Adrenergic Blockade on Left Ventricular Remodeling Among Hispanics and African Americans With Chronic Heart Failure

  2013cites this paper
• Cardiac sympathoexcitation in heart failure.

  2013cites this paper
• Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials

  2013cites this paper
• Torasemide

  2012cites this paper
• Reverse remodelling in a rat model of ardrenergic-induced cardiac dilatation and pump dysfunction

  2012cites this paper
• Central Angiotensin Type 1 Receptor Blockade Decreases Cardiac But Not Renal Sympathetic Nerve Activity in Heart Failure

  2012cites this paper
• Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.

  2012cites this paper
• Bucindolol: new hopes from reviewing past data.

  2011cites this paper
• Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.

  2011cites this paper
• Etiology-dependency of ionic remodeling in cardiomyopathic rabbits.

  2011cites this paper
• Treatment of chronic heart failure with β-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology.

  2011cites this paper
• Bucindolol: A Pharmacogenomic Perspective on Its Use in Chronic Heart Failure

  2011cites this paper
• Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach.

  2010cites this paper
• Meta-analysis: -Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure

  2009influential citation
• The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.

  2009cites this paper
• Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.

  2009cites this paper
• Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers.

  2008cites this paper
• Combined therapy with carvedilol and amiodarone is more effective in improving cardiac symptoms, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: Comparison with carvedilol therapy alone

  2008cites this paper
• Simultaneous Determination of Atenolol, Rosuvastatin, Spironolactone, Glibenclamide and Naproxen Sodium in Pharmaceutical Formulations and Human Plasma by RP‐HPLC

  2008cites this paper
• Enalapril and Losartan Are More Effective Than Carvedilol in Preventing Dilated Cardiomyopathy in the Syrian Cardiomyopathic Hamster

  2008cites this paper
• Cardiac failure in children

  2008cites this paper
• Chronic Administration of Carvedilol Improves Cardiac Function in 6-Month-Old Syrian Cardiomyopathic Hamsters

  2007cites this paper
• Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.

  2007cites this paper
• Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis.

  2007cites this paper
• Influence of medical intervention on sympathetic activity in heart failure

  2007cites this paper
• The effect of beta-blocker therapy on left ventricular systolic functions and functional capacity in patients with heart failure: a comparison between metoprolol succinate and carvedilol

  2006cites this paper
• Effect of beta‐blocker therapy on functional status in patients with heart failure — A meta‐analysis

  2006cites this paper
• The effect of carvedilol therapy on myocardial functional reserve in patients with advanced heart failure caused by nonischemic dilated cardiomyopathy.

  2006cites this paper
• Role of β‐Adrenoceptor Desensitization in Heart Failure

  2006cites this paper
• Beta‐Blockers for Treatment of Heart Failure in the Elderly

  2006cites this paper
• Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients.

  2005cites this paper
• Review of dilated cardiomyopathies. Dilated cardiomyopathies and altered prothrombotic state: a point of view of the literature.

  2005cites this paper
• Cardiac Remodeling: Mechanisms and Treatment

  2005influential citation
• Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study

  2005cites this paper
• A Randomized Trial of /-Blockade in Heart Failure The Cardiac Insufficiency Bisoprolol Study (CIBIS)

  2005cites this paper
• Prediction of the Effect of Bisoprolol in Dilated Cardiomyopathy

  2004cites this paper
• Management Of Heart Failure With Current Perspectives

  2004cites this paper
• Medical therapy in heart failure--is polypharmacy necessary?

  2004cites this paper
• Quantitative Gated SPECT Predicts Improvement of Cardiac Function After Carvedilol Treatment in Patients with Dilated Cardiomyopathy

  2004cites this paper
• [Beta-adrenoceptor antagonists in the treatment of chronic heart failure].

  2004cites this paper
• Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.

  2004cites this paper
• Chronic left ventricular failure in the community: Prevalence, prognosis, and predictors of the complete clinical recovery with return of cardiac size and function to normal in patients undergoing optimal therapy.

  2004cites this paper
• Dobutamine Stress 99 mTc-Tetrofosmin Quantitative Gated SPECT Predicts Improvement of Cardiac Function After Carvedilol Treatment in Patients with Dilated Cardiomyopathy

  2004cites this paper
• Efficacy of amiodarone treatment on cardiac symptom, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: Comparison with β-blocker therapy

  2004cites this paper
• The Effects of Beta Blockers on Morbidity and Mortality in Heart Failure

  2004cites this paper
• Beta Blocker and Angiotensin-Converting Enzyme Inhibitor Therapy Is Associated with Decreased Th1/Th2 Cytokine Ratios and Inflammatory Cytokine Production in Patients with Chronic Heart Failure

  2004cites this paper
• New concepts for why beta-blockers are helpful in heart failure

  2004cites this paper
• Use of beta-blockers in congestive heart failure

  2003cites this paper
• Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy.

  2003cites this paper
• Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.

  2003cites this paper
• Prevalence, predictors, and prognostic implications of improvement in left ventricular systolic function and clinical status in patients >70 years of age with recently diagnosed systolic heart failure.

  2003cites this paper
• Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial.

  2003cites this paper
• Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.

  2003cites this paper
• [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].

  2003cites this paper
• Is the Outcome of Cardiac Resynchronization Therapy Related to the Underlying Etiology?

  2003cites this paper
• Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS Trial): randomized controlled trial ☆

  2003cites this paper
• Beta-adrenoceptor blockers in chronic heart failure--a review.

  2003cites this paper
• Increased exercise ejection fraction and reversed remodeling after long‐term treatment with metoprolol in congestive heart failure: a randomized, stratified, double‐blind, placebo‐controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy

  2003cites this paper
• Beta blockers in heart failure.

  2003cites this paper
• Demographics and concomitant disorders in heart failure.

  2003cites this paper
• Beta-Blockers in Congestive Heart Failure: the Evolution of a New Treatment Concept - Mechanisms of Action and Clinical Implications

  2002cites this paper
• Effect of carvedilol on microcirculatory and glucose metabolic regulation in patients with congestive heart failure secondary to ischemic cardiomyopathy.

  2002cites this paper
• Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.

  2002cites this paper
• Einfluss des β-Rezeptorantagonisten Nebivolol auf hämodynamische Parameter, Verträglichkeit und Lebensqualität bei Patienten mit chronischer Herzinsuffizienz der NYHA-Klasse II und III zur Basistherapie (Herzglykosid, ACE-Inhibitor, Diuretikum)

  2002cites this paper
• Utilización de betabloqueadores en el tratamiento de la insuficiencia cardiaca

  2002cites this paper
• Beta-blockers: new standard therapy for heart failure.

  2002cites this paper
• Beta-blockers in left ventricular systolic dysfunction--from evidence to practice.

  2002cites this paper
• Bucindolol Displays Intrinsic Sympathomimetic Activity in Human Myocardium

  2002cites this paper
• β-Blockers: New standard therapy for heart failure

  2002cites this paper
• Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial.

  2001cites this paper
• Prognosis determination in heart failure.

  2001cites this paper
• The Role of Multiple Adrenergic Blockade in Coronary Artery Disease and Myocardial Infarction

  2001cites this paper
• Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis.

  2001cites this paper
• Nonselective Versus Selective &bgr;-Adrenergic Receptor Blockade in Congestive Heart Failure: Differential Effects on Sympathetic Activity

  2001cites this paper
• β-Blockade in Heart Failure

  2001cites this paper
• Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure

  2001cites this paper
• Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy.

  2001cites this paper
• Current role of beta-adrenergic blockers in the management of chronic heart failure.

  2001cites this paper
• Beta blockers in heart failure haemodynamics, clinical effects and modes of action.

  2001cites this paper
• β-BLOCKER THERAPY IN HEART FAILURE

  2001cites this paper
• What is the optimal medical management of ischaemic heart failure?

  2001cites this paper
• Beta‐blocker treatment in heart failure

  2001cites this paper
• Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis.

  2001cites this paper
• P-BLOCKER THERAPY IN HEART FAILURE

  2001cites this paper